The Australian laparoscopic non robotic radical prostatectomy experience - analysis of 2943 cases (USANZ supplement).

Louie-Johnsun MW, Handmer MM, Calopedos RJ, Chabert C, Cohen RJ, Gianduzzo TR, Kearns PA, Moon DA, Ooi J, Shannon T, Sofield D, Tan AH

Electrophysiological Determination of Submembrane Na(+) Concentration in Cardiac Myocytes.

Hegyi B, BĂĄnyĂĄsz T, Shannon TR, Chen-Izu Y, Izu LT

Ten-year outcomes using low dose rate brachytherapy for localised prostate cancer: An update to the first Australian experience.

Wilson C, Waterhouse D, Lane SE, Haworth A, Stanley J, Shannon T, Joseph D

Validation of the American version of the CareGiver Oncology Quality of Life (CarGOQoL) questionnaire.

Kaveney SC, Baumstarck K, Minaya-Flores P, Shannon T, Symes P, Loundou A, Auquier P

Enhancing active surveillance of prostate cancer: the potential of exercise medicine.

GalvĂŁo DA, Taaffe DR, Spry N, Gardiner RA, Taylor R, Risbridger GP, Frydenberg M, Hill M, Chambers SK, Stricker P, Shannon T, Hayne D, Zopf E, Newton RU

Self-injury in patients with intellectual disability.

Shannon T

Angiographic Cystoid Macular Edema and Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Shah N, Maguire MG, Martin DF, Shaffer J, Ying GS, Grunwald JE, Toth CA, Jaffe GJ, Daniel E, Comparison of Age-related Macular Degeneration Treatments Trials Research Group

Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.

Sharma S, Toth CA, Daniel E, Grunwald JE, Maguire MG, Ying GS, Huang J, Martin DF, Jaffe GJ, Comparison of Age-related Macular Degeneration Treatments Trials Research Group

Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).

Daniel E, Shaffer J, Ying GS, Grunwald JE, Martin DF, Jaffe GJ, Maguire MG, Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group

Sarcoplasmic Reticulum Structure and Functional Properties that Promote Long-Lasting Calcium Sparks.

Sato D, Shannon TR, Bers DM

Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Willoughby AS, Ying GS, Toth CA, Maguire MG, Burns RE, Grunwald JE, Daniel E, Jaffe GJ, Comparison of Age-Related Macular Degeneration Treatments Trials Research Group

Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT).

Altaweel MM, Daniel E, Martin DF, Mittra RA, Grunwald JE, Lai MM, Melamud A, Morse LS, Huang J, Ferris FL 3rd, Fine SL, Maguire MG, Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Comparison of Age-related Macular Degeneration Treatments Trials CATT Research Group

Managing aggression in global amnesia following herpes simplex virus encephalitis: The case of E.B.

Shannon TE, Griffin SL

Comparison of optical coherence tomography assessments in the comparison of age-related macular degeneration treatments trials.

Folgar FA, Jaffe GJ, Ying GS, Maguire MG, Toth CA, Comparison of Age-Related Macular Degeneration Treatments Trials Research Group

Sporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).

Kim BJ, Ying GS, Huang J, Levy NE, Maguire MG, CATT Research Group